Your browser doesn't support javascript.
loading
Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.
Hofmann, Felix O; Miksch, Rainer C; Weniger, Maximilian; Keck, Tobias; Anthuber, Matthias; Witzigmann, Helmut; Nuessler, Natascha C; Reissfelder, Christoph; Köninger, Jörg; Ghadimi, Michael; Bartsch, Detlef K; Hartwig, Werner; Angele, Martin K; D'Haese, Jan G; Werner, Jens.
Affiliation
  • Hofmann FO; Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians-University Hospital Munich, Marchioninistrasse 15, 81377, Munich, Germany.
  • Miksch RC; Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians-University Hospital Munich, Marchioninistrasse 15, 81377, Munich, Germany.
  • Weniger M; Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians-University Hospital Munich, Marchioninistrasse 15, 81377, Munich, Germany.
  • Keck T; Department of Surgery, University Clinic Schleswig-Holstein Campus Luebeck, Luebeck, Germany.
  • Anthuber M; Department of General, Visceral and Transplantation Surgery, University Hospital Augsburg, Augsburg, Germany.
  • Witzigmann H; Department of General and Visceral Surgery, Dresden-Friedrichstadt General Hospital, Dresden, Germany.
  • Nuessler NC; Department of General and Visceral Surgery, Munich Clinic Neuperlach, Munich Municipal Hospital Group, Munich, Germany.
  • Reissfelder C; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Köninger J; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.
  • Ghadimi M; Department of General Surgery, Klinikum Stuttgart, Stuttgart, Germany.
  • Bartsch DK; Department of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
  • Hartwig W; Department of Visceral-, Thoracic- and Vascular Surgery, Philipps-University Marburg, Marburg, Germany.
  • Angele MK; Department of General, Visceral and Oncologic Surgery, Evangelisches Krankenhaus, Duesseldorf, Germany.
  • D'Haese JG; Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians-University Hospital Munich, Marchioninistrasse 15, 81377, Munich, Germany.
  • Werner J; Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians-University Hospital Munich, Marchioninistrasse 15, 81377, Munich, Germany.
BMC Surg ; 22(1): 389, 2022 Nov 11.
Article in En | MEDLINE | ID: mdl-36368993
BACKGROUND: Non-resectability is common in patients with pancreatic ductal adenocarcinoma (PDAC) due to local invasion or distant metastases. Then, biliary or gastroenteric bypasses or both are often established despite associated morbidity and mortality. The current study explores outcomes after palliative bypass surgery in patients with non-resectable PDAC. METHODS: From the prospectively maintained German StuDoQ|Pancreas registry, all patients with histopathologically confirmed PDAC who underwent non-resective pancreatic surgery between 2013 and 2018 were retrospectively identified, and the influence of the surgical procedure on morbidity and mortality was analyzed. RESULTS: Of 389 included patients, 127 (32.6%) underwent explorative surgery only, and a biliary, gastroenteric or double bypass was established in 92 (23.7%), 65 (16.7%) and 105 (27.0%). After exploration only, patients had a significantly shorter stay in the intensive care unit (mean 0.5 days [SD 1.7] vs. 1.9 [3.6], 2.0 [2.8] or 2.1 [2.8]; P < 0.0001) and in the hospital (median 7 days [IQR 4-11] vs. 12 [10-18], 12 [8-19] or 12 [9-17]; P < 0.0001), and complications occurred less frequently (22/127 [17.3%] vs. 37/92 [40.2%], 29/65 [44.6%] or 48/105 [45.7%]; P < 0.0001). In multivariable logistic regression, biliary stents were associated with less major (Clavien-Dindo grade ≥ IIIa) complications (OR 0.49 [95% CI 0.25-0.96], P = 0.037), whereas-compared to exploration only-biliary, gastroenteric, and double bypass were associated with more major complications (OR 3.58 [1.48-8.64], P = 0.005; 3.50 [1.39-8.81], P = 0.008; 4.96 [2.15-11.43], P < 0.001). CONCLUSIONS: In patients with non-resectable PDAC, biliary, gastroenteric or double bypass surgery is associated with relevant morbidity and mortality. Although surgical palliation is indicated if interventional alternatives are inapplicable, or life expectancy is high, less invasive options should be considered.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Surg Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Surg Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom